Agilent SLIMS
Sourced profiles of MES, QMS and LIMS products. Dataset as of 2026-10-04.
- Vendor
- Agilent
- Category
- LIMS (vendor also describes ELN and LES in the same product)
- Deployment
- On premise, cloud hosted by Agilent, or cloud hosted by the customer.
- Pricing stance
- Quote-only
- Regulatory posture
- Vendor: technical controls for labs that must follow 21 CFR Part 11, EU Annex 11, and GAMP 5. Not a certificate. Same product is also described as ELN and LES.
- Independent review
- Passed 2026-10-02
- Sourced claims
- 54
Product: Agilent SLIMS ("smart" LIMS), a combined LIMS, ELN, and laboratory execution system (LES). Formerly Genohm SLIMS. Vendor: Agilent Technologies, Inc. (NYSE: A), 5301 Stevens Creek Blvd., Santa Clara, CA 95051. Acquired with Genohm (Lausanne) in 2018. Category: LIMS and lab execution software for pharma QC, biobanks, NGS, analytical, cannabis, and PFAS labs. Not an MES, CDS, or QMS. Verification date: 2026-10-02. Scope: Public web sources only.
1. Overview
Agilent SLIMS is a combined LIMS, ELN, and lab execution system that Agilent bought with Genohm in 2018, built for biobanks and NGS labs and now pitched to pharma QC through stability studies and a direct OpenLab CDS handoff. Its best-documented public buyers are FDA, whose CFSAN Genomics Information Management System (GIMS) has run on SLIMS licences since 2014, and the UK Health Security Agency, which runs it as a critical dependency in its genome-sequencing labs.
Agilent says SLIMS "combines the best of a LIMS and an ELN in a single Laboratory execution system (LES)." It tracks each sample from reception, storage, and processing through results, and runs in a web browser on a computer or tablet. (Agilent SLIMS explore page.) Agilent targets pharmaceutical labs that need compliance controls, biobanks, NGS labs, analytical labs, cannabis testing, and PFAS testing. At acquisition, SLIMS served biobanks, research labs, and NGS facilities. (EPFL-hosted announcement PDF, 2 May 2018.) Agilent says labs in more than 20 countries use it.
In one application, a lab tracks samples and locations, executes protocols, integrates instruments, keeps versioned SOPs, reviews by exception, and signs and audits records. The pharma configuration adds stability studies, a workflow module, resource and calibration control, and a chromatography handoff.
Outside SLIMS:
- OpenLab CDS is Agilent's separate chromatography data system. SLIMS sends sequences to it and takes results back. At acquisition, Agilent's John Sadler said SLIMS's architecture is "aligned with" OpenLab. (Pharma page.)
- iLab and the Alissa Platform (including Alissa Interpret) are separate Agilent products SLIMS connects to. (NGS page.)
- MES, ERP, QMS, and billing are external; SAP and billing systems are named integration examples.
2. Company and product identity
| Point | Fact | Source |
|---|---|---|
| Name | "Smart" LIMS: SLIMS. Agilent defines an LES as LIMS plus ELN. | Explore page |
| Genohm origins | Founded in Ghent, Belgium, in 2002 as a two-person bioinformatics shop; an EPFL start-up at Innovation Park, Lausanne, from 2011. Founder and CEO Frederik Decouttere. | 2 May 2018 release |
| Genohm at acquisition | SLIMS was its main lab automation suite, a LIMS and ELN tracking samples, tests, users, results, and workflows from material shipment through instrument results and analysis pipelines, with an app marketplace of preconfigured workflows. Offices in Lausanne, Ghent, and Durham, NC; 40 employees (40+ in the boilerplate); customers in Europe, the Middle East, Asia Pacific, and the US. | 2 May 2018 release |
| Acquisition | Definitive agreement 2 May 2018; completed 14 May 2018. Terms undisclosed. Agilent bought LIMS and workflow management and broader ELN capability to give its analytical data more context. Sadler was VP and GM of Software and Informatics; Kamni Vijay, VP and GM of Genomics, tied the deal to NGS workflows. | EPFL PDF; Investor release |
| Seller today | Agilent Technologies, Santa Clara. In the UK: Agilent Technologies Lda UK Limited. | Pharma page; UK notices |
3. Pharma and biotech relevance
Agilent pitches SLIMS to QC labs as "not just another LIMS": it covers bench execution as well as sample tracking, and can sit beside an existing LIMS or replace it. The pharma page names review by exception, signatures, an audit trail, stability studies, and instrument and material checks so only approved instruments and in-date materials are used. (Pharma page.)
- Part 11, Annex 11, GAMP 5. SLIMS "provides the technical controls" to acquire, process, report, and store data under FDA 21 CFR Part 11, EU Annex 11, GAMP 5, ISO/IEC 17025, and EPA 40 CFR Part 160. Agilent's Part 11 / Annex 11 white paper for SLIMS is part number 5994-5125EN; a search extract of it says Agilent develops and tests SLIMS under ISO 9001:2015, performs IQ/OQ, and leaves PQ and system validation to the customer. (Explore page.)
- Clinical NGS. Agilent says the audit history "helps you meet your 21 CFR part 11 compliance obligations" and can "streamline compliance with HIPAA, CLIA, CAP and more." (NGS page.)
- Biobanking. SLIMS supports ISO 20387:2018, ISBER recommendations, and SPREC nomenclature, with chain of custody, consent, and freezer and EMR integration. (Biobank page.)
- Pharma QC workflows. Stability studies (storage conditions, packaging, timepoints, specifications, trending); a workflow module that chains step outputs into later tests; barcode design; versioned SOPs; and a six-step OpenLab CDS sequence handoff. A "Biopharma QC Digital Transformation" application note and a pharma brochure are gated.
FDA's site search could not be queried on 2 Oct 2026, and web searches that day found no FDA or EMA regulatory record naming SLIMS or Genohm. FDA is itself a SLIMS buyer (section 7).
4. Capabilities
| Capability | Type | What Agilent documents | Source |
|---|---|---|---|
| Sample tracking | Native | Reception, storage, and processing through results; location, assignment, aliquoting, mixing, barcodes. | Explore page |
| LIMS + ELN + LES | Native | Sample-centric LIMS and workflow-driven ELN in one system. | Explore FAQ; pharma page |
| Protocol execution | Native | Step guidance, review by exception, signatures, audit trail, reports. | Explore FAQ; pharma page |
| Stability | Module | "Stability Module": temperature, humidity, photolysis, packaging, timepoints, specifications, pull plans, trending. | Pharma page |
| Workflow module | Module | One step's output feeds the next (one preparation used for both a pH test and an HPLC test); live view of who is on which task. | Pharma page |
| SLIMS Store | Content packages | Sample types, locations, metadata, automation snippets, premade configurations. NGS index sets for Agilent SureSelect, Illumina Nextera XT, BGI, and 10x Genomics, plus Excel upload of custom sets. A default SureSelect XT on NovaSeq workflow deploys "in minutes." | Explore, pharma, NGS pages |
| Instrument integration | Native | Results captured without retyping. Named: OpenLab CDS, TapeStation (automatic), Illumina BaseSpace, EMR plugins. | Pharma, biobank, NGS pages |
| OpenLab CDS handoff | Native | Client request; sequence built in SLIMS; sent to the CDS; processed in OpenLab CDS Data Analysis; results returned without retyping; approved report to the client. Agilent also says SLIMS "can interface with any" CDS. | Pharma page |
| Resources and calibration | Native | Reagents, locations, calibration, maintenance; use restricted to approved instruments and valid chemicals. | Pharma page |
| Biobank operations | Native | Studies, subject registration, visits, collection events, chain of custody, configurable annotations, longitudinal timepoints, consent. | Biobank page |
| API | Native | "APIs, which allow communication with third-party tools"; "Use the SLIMS API to connect" to the customer's pipeline. | Explore page; NGS page |
| Services | Service | Installation, verification, configuration with the customer, validation, and training of designated users to make later changes. | Explore, pharma, biobank, NGS pages |
Agilent publishes no version number, database, browser list, or data-residency region.
5. Architecture and deployment
Three options: on-premises, cloud hosted by Agilent, or cloud hosted by the customer ("your favorite cloud service provider"). SaaS is supported. Deployment is "quick and 100% remote." The browser client means no client-software maintenance cost. (Explore page.) Genohm already offered on-premises and cloud versions in 2018. The architecture "scales" for data-intensive, multi-site labs across time zones. (NGS page.)
6. Integrations
| Interface | What Agilent documents |
|---|---|
| OpenLab CDS | "Automated, secure, and easy to implement." Sequence tables go to the CDS and results return to the test protocol; instruments can be set as required or next-available. |
| Any CDS | "SLIMS can interface with any chromatography data system (CDS)." |
| TapeStation | Automatic connection; results flow into SLIMS. |
| NGS | Illumina BaseSpace core workflows; SureSelect, Nextera, BGI, and 10x index sets. |
| Alissa Interpret | Integrated in the NGS pipeline. |
| iLab | Named integration. |
| EMR and freezers | "Integration with freezer management systems, instruments, and hospital EMR systems"; EMR plugins. No EMR vendor named. |
| SAP, billing, identity | "Many business packages (such as identify management software, SAP, or billing systems)." |
| API | Open API to third-party tools and pipelines. A third-party catalog (APIs.io) says the SLIMS REST API comes with a SLIMS license. |
7. Pricing and commercial model
Pricing is quote-only. Agilent publishes no SLIMS list price. Its FAQ says cost depends on number of users, functions needed, deployment method, and access, and argues for lower running cost: no client maintenance, SaaS support, Store configurations that shorten implementation, and trained users who handle routine changes without buying services. (Explore FAQ.)
UK contract terms describe the model: annual license subscriptions paid upfront per one-year period (a three-year subscription billed as three invoices), added user licenses priced at the contracted rate for the period, and services billed after delivery on time and materials under a quote and a "SLIMS Supplementary Terms & Conditions / SLIMS Cloud Software Master Agreement."
Agilent's GSA schedule GS-07F-0564X (1 June 2011 to 31 May 2026; SINs 334516 and 532490L on the cover, 531490L in the SIN table) does not list SLIMS in its August 2022 price list. (GSA PDF.) FDA nonetheless ordered a SLIMS licence renewal under that schedule in 2023 (below), so SLIMS is bought through the vehicle without a published schedule price.
Public contract records
| Notice | Buyer | Supplier | Scope | Value |
|---|---|---|---|---|
| Contracts Finder; Sell2Wales "PHE - ICT - Agilent LIMS for Colindale (Genome) STA" (cites Contracts Finder 31682) | Public Health England | AGILENT TECHNOLOGIES LDA UK LIMITED | "Implementation and licensing of Agilent SLIMS (lab information system) for genome sequencing"; awarded 20 May 2021, contract 21 May to 30 September 2021 | £184,000 (VAT treatment not stated) |
| Contracts Finder; Find a Tender 2025/S 000-043798 (ocid ocds-h6vhtk-0567eb, published 29 July 2025) | UK Health Security Agency (Secretary of State for Health and Social Care) | Agilent Technologies Lda UK Limited | "Agilent SLIMS 2025-2026 Licenses Renewal," 1 July 2025 to 30 June 2026; S-LIMS is a critical dependency for UKHSA sequencing labs | £69,315.24 excluding VAT; £83,178.29 including VAT |
| Contracts Finder CF-1022000D0O000000rwimUAA (DPS call-off) | UK Health Security Agency | Insight Direct (UK) Ltd (reseller) | 2022-23: "92 Named Premium Agilent SLIMS Licences, 1 Additional Agilent SLIMS Server Licence" | £104,329.10 |
| Contracts Finder CF-1755100D0O000000rwimUAA (framework call-off) | UK Health Security Agency | Insight Direct (UK) Ltd (reseller) | 2023-24 renewal | £112,807.41 |
None of the amounts in this section is a list price. They are award, obligation, or framework values, and none should be divided into a per-user price.
FDA (Office of Acquisitions & Grant Services; CFSAN programme): Genomics Information Management System (GIMS). FDA's 2025 sources-sought notice and RFQ state that GIMS runs on Agilent SLIMS user and server licences, and the RFQ asks to upgrade "FDA currently Agilent SLIMS version to version 6.9." Awards described only as GIMS are attributed to SLIMS through that link.
| Award (USAspending) | Recipient | Signed | Obligated (USD) | Description |
|---|---|---|---|---|
| HHSF223201400041A | Genohm Inc | 2014-03-12 | 198,136.00 | GIMS; performance to 2019-03-31 (SAM award notice FDA-SOL-14-1128885) |
| HHSF223201410185A | Genohm Inc | 2014-08-23 | 7,461.83 | 10 SLIMS user licenses, one option year |
| HHSF223201510362A | Genohm Inc | 2015-08-11 | 37,590.00 | 30 SLIMS user licenses |
| HHSF223201610039I (IDIQ) | Genohm Inc | 2016-09-13 | 0 on the vehicle; ceiling 6,500,000 | GIMS software and services IDIQ to 2021-09-14. The ceiling is not a price paid. |
| HHSF22301001T | Genohm Inc | 2016-09-15 | 36,450.00 | 30 annual GIMS licenses (IDIQ order) |
| HHSF22301003T | Genohm Inc | 2016-09-20 | 63,079.86 | GIMS development services |
| HHSF22301002T | Genohm Inc | 2017-07-17 | 43,375.50 | 35 SLIMS software licenses |
| HHSF22301004T | Genohm Inc | 2017-08-17 | 141,248.00 (187,072.00 with options) | GIMS development |
| 75F40118F01005 | Genohm Inc | 2018-09-13 | 113,475.50 | GIMS DME |
| 75F40119F19006 | Genohm Inc | 2019-08-15 | 78,205.00 | CFSAN GIMS upgrade FY19 |
| 75F40121P00612 | Agilent Technologies, Inc. | 2021-09-21 | 56,108.00 | GIMS and customization |
| 75F40122P00590 | Agilent Technologies Inc | 2022-09-29 | 42,993.00 | GIMS and customization |
| 75F40123F80361 | Agilent Technologies Inc | 2023-09-08 | 90,574.00 | "SLIMS LICENSES RENEWAL," ordered under GSA schedule GS07F0564X; performance to 2025-09-20 |
| 75F40125P00276 | Agilent Technologies Inc | 2025-09-24 | 119,162.26 | GIMS licence renewal, support, and modernization (HHS OMAS buying centre for FDA) |
| 75F40126P00187 | Agilent Technologies Inc | 2026-09-08 | 42,034.00 | GIMS licence renewal, support, and modernization; performance 2026-09-21 to 2027-09-20 |
Genohm was Agilent-owned from 14 May 2018, so the two later orders still made out to Genohm Inc (13 September 2018 and 15 August 2019) are post-acquisition orders. Awards to Agilent Technologies start in 2020 (NASA, below).
FDA solicitations without amounts show the deal shape. A 2020 sole-source notice of intent to Agilent covers renewal of 35 named-user SLIMS licences plus upgrades and integration of Illumina, Pacific Biosciences, and Nanopore sequencers. A 2023 RFQ covers 15 named-user licences for 12 months, extra server licensing, and consulting hours. The June 2026 RFQ-75F40126Q00250 lists Premium (7), Standard (10), and Basic (72) named-user licences plus 2 server licences, with the price cells blank. Those are licence tier names, not prices.
NASA Shared Services Center, for NASA Ames. 80NSSC20P1206, "SLIMS SOFTWARE," USD 51,516.93, signed 28 May 2020 (SAM notice 4200730020). 80NSSC24PA527, "SLIMS SOFTWARE," USD 30,764.16, signed 14 February 2024, performance 21 January 2024 to 21 January 2025, after sole-source notice 80NSSC24859925Q.
EU TED: Département de la Drôme, France. TED 276473-2020, published 15 June 2020: supply, implementation, and maintenance of a LIMS for the departmental laboratory, including interfaces, data migration, training, and sampler tablets. Concluded 27 April 2020 with eight tenders; contractor Genohm (Lausanne); value EUR 584,955.50. SLIMS is not named, and the value also covers services and hardware.
Excluded: TED 289445-2026 (KTH). This is KTH's laboratory and research equipment framework, with 53 tenderers, one of them Agilent Technologies Sweden AB. SLIMS does not appear in it; the only "Slim" is the surname of a Merck Life Science AB contact. Its SEK 950,000,000 framework maximum is not a SLIMS price. TED 226490-2025 (Latvian dental materials) is likewise unrelated.
Questions a buyer should ask
- What is the license metric: named user, concurrent user, site, instrument, or module? Does the UK three-year subscription structure still apply?
- What does the subscription cover, and what is time-and-materials (installation, configuration, validation, integration)?
- Which environments (production, validation, training) are included?
- Agilent cloud, customer cloud, or on-prem: who holds the data, and is each a different SKU?
- Are OpenLab CDS, TapeStation, Alissa, and BaseSpace links included or separately licensed?
- What does "100% remote" deployment require from the customer?
- Is 5994-5125EN the Part 11 package, and is IQ/OQ a paid service?
- Which Store packages (NGS, stability) are in the license?
- Can users be added mid-term at the contracted price?
- If SLIMS runs beside an existing LIMS, how are the two systems' scopes split?
8. Implementation and validation support
Agilent installs SLIMS, verifies it "performs exactly as designed," configures it with the customer, and trains designated users to make later changes. There is no "big bang" cutover; the lab sets the pace. Store packages accelerate setup, and routine maintenance should not take "days of professional services." Validation is part of the engineering support. (Pharma page; Explore FAQ.) Per the white-paper extract, Agilent does IQ/OQ and the customer does PQ. No validation plan template or GAMP category is published, and Agilent's general computer-system-validation services do not name SLIMS.
doTERRA "saved over 50 hours a week by replacing paper workflows with SLIMS" (Agilent teaser; case study 5994-8360EN). (Explore page.)
9. Customer evidence
| Account | Evidence | Limit |
|---|---|---|
| FDA (CFSAN GIMS) | Fifteen USAspending awards 2014 to 2026 for GIMS and SLIMS licences, upgrades, and development (including a USD 6.5 million IDIQ ceiling); 2026 RFQ for Premium (7), Standard (10), and Basic (72) named-user licences plus 2 server licences. | Public procurement record. Award values, not list prices. |
| NASA Ames (via NASA Shared Services Center) | "SLIMS SOFTWARE" orders, USD 51,516.93 (2020) and USD 30,764.16 (2024). | Public procurement record. |
| UK Health Security Agency / Public Health England | £184,000 implementation and licensing for genome sequencing (2021); reseller renewals of £104,329.10 (2022-23, 92 named premium licences and 1 server licence) and £112,807.41 (2023-24) through Insight Direct; £69,315.24 renewal for 2025-26; SLIMS described as a critical dependency. | Public procurement record. |
| Département de la Drôme laboratory (France) | EUR 584,955.50 LIMS award to Genohm, 2020. | Public procurement record. SLIMS not named; includes services and hardware. |
| doTERRA | Saved over 50 hours a week replacing paper workflows. | Vendor teaser. |
| FlyORF | Unattributed biobank-page quote: SLIMS handles internal and external orders, strain-collection browsing, sample management, and billing in one system. | No person or year. |
| Unnamed hospital | SLIMS tracks samples across hospitals, links subjects, samples, protocols, and results; ELN tracks sequencing runs. | Unnamed. |
| Unnamed biobank cohort | SLIMS "selected to manage our biobank and cohort," with cross-institution access and data protection. | Unnamed. |
| Unnamed reagent and animal lab | Reagents, antibodies, and mice in one system. | Unnamed. |
| Other explore-page quotes | SLIMS as the "keystone" of operations (equipment integration, SOP repository); ELN "indispensable" for a biobank. | Unnamed. |
10. Competitive and third-party context
No Gartner, Forrester, IDC, or LNS evaluation of SLIMS is cited, and no trade-press or ISPE article names a SLIMS site. Within Agilent's own stack, SLIMS is the sample and lab-execution layer and OpenLab CDS is the chromatography system it hands work to.
11. Changes and renames
- 2002: Genohm founded in Ghent. 2011: moves to EPFL Innovation Park, Lausanne.
- 2014-03-12: FDA's first GIMS award to Genohm; FDA orders continue through 2026.
- 2018-05-02: Agilent agrees to buy Genohm. 2018-05-14: deal completes. Genohm SLIMS becomes Agilent SLIMS.
- 2020: NASA Ames buys SLIMS; Drôme laboratory LIMS awarded to Genohm.
- 2021: Public Health England buys SLIMS for genome sequencing.
- 2025: Agilent markets SLIMS as LIMS + ELN + LES with three deployment models, pharma stability, the OpenLab CDS handoff, NGS Store content, and ISO 20387 biobank support. UKHSA renews licenses for 2025-26.
12. Source library
Pages retrieved 2026-10-02. Full URL list: sources note. Every claim above is in the product's evidence set with its source, type, and confidence.
Primary pages:
- https://explore.agilent.com/AgilentSLIMS
- https://explore.agilent.com/agilentslims-pharma
- https://explore.agilent.com/agilentslims-biobanks
- https://explore.agilent.com/agilentslims-ngs
- https://documents.epfl.ch/groups/e/ep/epflmedia/www/20180502_Genohm/Final%20Press%20Release%20Genohm%20Acquisition.pdf
- https://www.investor.agilent.com/news-and-events/news/news-details/2018/Agilent-Completes-Acquisition-of-Genohm/default.aspx
- https://www.contractsfinder.service.gov.uk/notice/8173e439-410b-477f-a141-8d61525a6514
- https://www.contractsfinder.service.gov.uk/notice/76ce71f5-6fff-43ae-908c-564defb71342
- https://www.find-tender.service.gov.uk/Notice/043798-2025
Sources note
Sources: Agilent SLIMS
Sources as of 2 Oct 2026. Each entry gives the source and what it supports in the profile.
Vendor and company
- The best of LIMS & ELN in one software: Positioning, deployment, Part 11 claim, integrations list, pricing FAQ, doTERRA teaser, 20-country claim
- LIMS for Pharmaceutical Labs: QC positioning, stability, workflow, OpenLab CDS handoff, implementation wording
- LIMS for Biobanks: ISO 20387 / ISBER / SPREC language, TapeStation, FlyORF quote
- LIMS for NGS: Alissa, BaseSpace, index sets, Part 11 example, unattributed hospital quote
- Agilent Completes Acquisition of Genohm: 14 May 2018 closing. Terms not disclosed.
- Acquisition announcement, dateline 2 May 2018: Agreement, Genohm history, SLIMS description, OpenLab alignment quote
Press and third parties
- APIs.io plan catalog: Seen in search. Says API access comes with a SLIMS license and that Agilent quotes the price.
Procurement
- Agilent SLIMS 2025-2026 Licenses Renewal: Opened. Total value £69,315.24. Range £69,315.24 to £83,178.29. UKHSA / Agilent Technologies Lda UK Limited.
- PHE implementation and licensing of Agilent SLIMS for genome sequencing: Opened. Total value £184,000. Public Health England / AGILENT TECHNOLOGIES LDA UK LIMITED.
- Agilent SLIMS 2025/2026: Opened. £69,315.24 ex VAT, £83,178.29 inc VAT. 1 Jul 2025–30 Jun 2026.
- OCDS release for the same notice: amount 69315.24, amountGross 83178.29, currency GBP.
- GSA FSS document, August 2022, GS-07F-0564X: Archive copy of the same file read. Does not name SLIMS.
- Scope-of-work attachment: Search extract of subscription and time-and-materials terms. No amount in the extract.
- USAspending award HHSF223201400041A: FDA awarded Genohm, Inc. USD 198,136.00 for the Genomic Information Management System (GIMS) on 2014-03-12, with performance to 2019-03-31.
- USAspending award HHSF223201410185A: FDA bought 10 SLIMS user licenses with one option year from Genohm, Inc. for USD 7,461.83, signed 2014-08-23.
- USAspending award HHSF223201510362A: FDA bought 30 SLIMS user licenses from Genohm, Inc. for USD 37,590.00, signed 2015-08-11.
- USAspending award HHSF223201610039I: FDA set up a GIMS software-and-services IDIQ with Genohm, Inc. on 2016-09-13 with a USD 6,500,000 base-and-all-options ceiling and USD 0 obligated on the vehicle itself.
- USAspending award HHSF22301001T: FDA ordered 30 annual Genomics Information Management software licenses from Genohm, Inc. for USD 36,450.00 under IDIQ HHSF223201610039I, signed 2016-09-15.
- USAspending award HHSF22301003T: FDA ordered GIMS development services (workflow and latency analysis, new instrument integration) from Genohm, Inc. for USD 63,079.86, signed 2016-09-20.
- USAspending award HHSF22301002T: FDA ordered 35 SLIMS software licenses from Genohm, Inc. for USD 43,375.50 under IDIQ HHSF223201610039I, signed 2017-07-17.
- USAspending award HHSF22301004T: FDA ordered GIMS software development for new instruments and lab-workflow improvements from Genohm, Inc.: USD 141,248.00 obligated and USD 187,072.00 base and all options, signed 2017-08-17.
- USAspending award 75F40118F01005: FDA ordered "GIMS DME" from Genohm, Inc. for USD 113,475.50 under IDIQ HHSF223201610039I, signed 2018-09-13.
- USAspending award 75F40119F19006: FDA ordered a CFSAN GIMS upgrade for FY19 from Genohm, Inc. for USD 78,205.00, signed 2019-08-15.
- USAspending award 80NSSC20P1206: NASA Shared Services Center bought "SLIMS SOFTWARE" from Agilent Technologies Inc for USD 51,516.93, signed 2020-05-28.
- USAspending award 75F40121P00612: FDA bought GIMS and customization from Agilent Technologies, Inc. for USD 56,108.00, signed 2021-09-21.
- USAspending award 75F40122P00590: FDA bought GIMS and customization from Agilent Technologies Inc for USD 42,993.00, signed 2022-09-29.
- USAspending award 75F40123F80361: FDA ordered a SLIMS licenses renewal from Agilent Technologies Inc for USD 90,574.00 under GSA schedule GS07F0564X, signed 2023-09-08, performance to 2025-09-20.
- USAspending award 80NSSC24PA527: NASA Shared Services Center bought "SLIMS SOFTWARE" from Agilent Technologies Inc for USD 30,764.16, signed 2024-02-14, performance 2024-01-21 to 2025-01-21.
- USAspending award 75F40125P00276: HHS bought a GIMS license renewal, support, and modernization for FDA from Agilent Technologies Inc for USD 119,162.26, signed 2025-09-24.
- USAspending award 75F40126P00187: FDA bought a GIMS license renewal, support, and modernization from Agilent Technologies Inc for USD 42,034.00, signed 2026-09-08, performance 2026-09-21 to 2027-09-20.
- SAM.gov FDA-SOL-14-1128885: Genomic Informaton Management System: SAM award notice FDA-SOL-14-1128885 publishes the 2014 FDA GIMS award HHSF223201400041A to Genohm, Inc. at USD 198,136.00.
- SAM.gov FDA-20-NOI-1228989: Notice of Intent to Sole Source - GIMS System -SLIMS Software Licenses and Software Customization: FDA published a 2020 notice of intent to sole-source the renewal of 35 named-user SLIMS licenses plus customization and sequencer integration to Agilent Technologies Inc.
- SAM.gov 4200730020: Software - SLIMS: A NASA Shared Services Center notice of 2020-05-12 for "Software - SLIMS" at Moffett Field, CA precedes USAspending award 80NSSC20P1206 to Agilent.
- SAM.gov FDA-75F40123Q000416: Genomic Information Management System (GIMS) / SLIMS Licenses: FDA's 2023 GIMS/SLIMS solicitation asked for renewal of 15 named-user SLIMS licenses for 12 months, extra server licensing, and SLIMS consulting hours.
- SAM.gov 80NSSC24859925Q: Slims Software: NASA Shared Services Center announced on 2024-02-01 an intent to sole-source SLIMS software for NASA Ames to Agilent Technologies Inc.
- SAM.gov FDA-RFI-25-130585: Genomics Information Management System (GIMS) License Renewal and Support: FDA's 2025 sources-sought notice states that GIMS runs on SLIMS user and server licences and asks for brand-name-or-equal renewal of 15 named-user SLIMS licences.
- SAM.gov FDA-RFQ-75F40125Q00403: Genomics Information Management System (GIMS) License Renewal, Support, and Modernization: FDA's September 2025 RFQ named Agilent SLIMS as the GIMS platform and asked for licence renewal plus an upgrade to SLIMS version 6.9.
- SAM.gov RFQ-75F40126Q00250: Genomics Information Management System (GIMS) License Renewal, Support,: FDA's June 2026 RFQ lists SLIMS licence tiers as Premium, Standard, and Basic named users plus Server licences (7, 10, 72, and 2) from 2026-09-21.
- TED 276473-2020: France-Valence: Miscellaneous software package and computer systems: Département de la Drôme awarded Genohm a LIMS supply, implementation, and maintenance contract for its departmental laboratory worth EUR 584,955.50, concluded 2020-04-27.
- TED 289445-2026, KTH laboratory and research equipment framework: Matched "SLIMS AND Agilent". Lab and research equipment framework, 53 tenderers incl. Agilent Technologies Sweden AB. Only "slim" is a Merck Life Science AB contact surname ("Magnus Waldman Slim"); no SLIMS content. Excluded
Regulators
- EudraGMDP description: Returned by a search for SLIMS/Genohm on ema.europa.eu. No SLIMS record identified.